ストックスクリーナーアプリを入手
52.05
12.86%
5.93
アフターアワーズ：
51.92
-0.13
-0.25%
前日終値:
$46.12
開ける：
$47.555
24時間の取引高:
5.08M
Relative Volume:
0.82
時価総額：
$9.37B
収益：
$1.36B
当期純損益:
$-302.91M
株価収益率:
-30.29
EPS:
-1.7182
ネットキャッシュフロー:
$-219.93M
1週間 パフォーマンス:
+18.65%
1か月 パフォーマンス:
-13.38%
6か月 パフォーマンス:
-5.21%
1年 パフォーマンス:
-11.39%
1日の値動き範囲:
$47.23
$52.40
1週間の範囲:
$42.40
$52.40
52週間の値動き範囲:
$40.77
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Compare TEM vs VEEV, BTSG, HQY, HNGE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
52.05 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
230.47 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
62.43 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
104.63 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
89.33 | 5.81B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-13 | 開始されました | Jefferies | Underperform |
| 2026-04-13 | アップグレード | TD Cowen | Hold → Buy |
| 2026-02-19 | 開始されました | Mizuho | Outperform |
| 2026-02-17 | 開始されました | Robert W. Baird | Outperform |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-10-21 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-10-20 | 開始されました | Canaccord Genuity | Buy |
| 2025-09-02 | 開始されました | H.C. Wainwright | Buy |
| 2025-04-21 | 開始されました | BTIG Research | Buy |
| 2025-02-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-02-12 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | 再開されました | TD Cowen | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Outperform |
| 2024-12-09 | 開始されました | Guggenheim | Buy |
| 2024-11-11 | ダウングレード | Stifel | Buy → Hold |
| 2024-10-02 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-08-12 | 開始されました | Piper Sandler | Neutral |
| 2024-07-09 | 開始されました | BofA Securities | Buy |
| 2024-07-09 | 開始されました | JP Morgan | Overweight |
| 2024-07-09 | 開始されました | Longbow | Buy |
| 2024-07-09 | 開始されました | Loop Capital | Buy |
| 2024-07-09 | 開始されました | Morgan Stanley | Overweight |
| 2024-07-09 | 開始されました | Needham | Buy |
| 2024-07-09 | 開始されました | Stifel | Buy |
| 2024-07-09 | 開始されました | TD Cowen | Buy |
| 2024-07-09 | 開始されました | William Blair | Outperform |
すべてを表示
Tempus Ai Inc (TEM) 最新ニュース
Tempus AI (NASDAQ:TEM) Hits New 52-Week LowTime to Sell? - MarketBeat
Tempus AI Inc stock hits 52-week low at 41.7 USD - Investing.com Canada
Eagle Health Investments LP Takes Position in Tempus AI, Inc. $TEM - MarketBeat
TEM|Tempus AI Inc|Price:42.930|Chg%:+0.240 - TradingKey
Artificial Intelligence Stocks To Keep An Eye OnJuly 27th - MarketBeat
Tempus AI Stock (TEM) Opinions on Personalis Acquisition and Analyst Upgrades - Quiver Quantitative
Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring - Oncodaily
Tempus AI, Inc. (TEM) Stock Analysis: Exploring the 55.94% Potential Upside and Analyst Ratings - DirectorsTalk Interviews
Tempus AI Inc (TEM) Balance Sheet - TradingKey
AI Stocks: Why Tempus AI (NASDAQ:TEM), Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrodinger (NASDAQ:SDGR) Are in Focus - Kalkine Media
Tempus AI Inc (TEM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tempus AI Inc (TEM) Income Statement - TradingKey
Alan Tan: Highlighting Ultrasensitive MRD Detection with Tempus AI at KCRS26 - Oncodaily
136,636 Shares in Tempus AI, Inc. $TEM Acquired by Aristotle Atlantic Partners LLC - MarketBeat
Tempus AI (NASDAQ:TEM) Shares Fall 19% as Attention Turns to Merger Collar - TechStock²
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Brainsway (BWAY) and Argenx Se (ARGX) - The Globe and Mail
Tempus AI Inc (TEM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tempus AI Inc (TEM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tempus AI Inc|Price:42.690|Chg%:-3.320 - TradingKey
Tempus AI (NASDAQ:TEM) Upgraded to Hold at Wall Street Zen - MarketBeat
Tempus AI stock: H.C. Wainwright reiterates Buy on MRD expansion - Investing.com UK
Tempus AI buys Personalis for $1.5B; UCSF Health, Kleiner Perkins and Doerr Capital launch health AI accelerator; Candid Health raises $120M - VatorNews
Tempus AI Stock Before Q2 Earnings Release: To Buy, Hold or Sell? - Yahoo Finance
Tempus to acquire Personalis in $1.5 billion deal to expand MRD capabilities - DOTmed
Tempus AI stock: H.C. Wainwright reiterates Buy on MRD expansion By Investing.com - Investing.com Canada
GC Wealth Management RIA LLC Cuts Position in Tempus AI, Inc. $TEM - MarketBeat
Cathie Wood buys $8.7 million of beaten-down AI stock - thestreet.com
Artificial Intelligence Stocks To Follow NowJuly 23rd - MarketBeat
Tempus AI (TEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo! Finance Canada
Tempus AI (TEM) Expected to Announce Earnings on Thursday - MarketBeat
Tempus AI (TEM) Unveils National Rollout of Pharmacogenomics Tes - GuruFocus
Tempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic Patients - Stocktwits
Tempus makes $1.5B bet to corner cancer-test market - thestreet.com
Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring - Sahm
What's behind Tempus AI's latest 3.5% stock pullback? - Traders Union
Best Artificial Intelligence Stocks To Follow TodayJuly 22nd - MarketBeat
Why is Tempus AI stock sliding today? By Investing.com - Investing.com Canada
Tempus AI launches pharmacogenomics testing nationwide By Investing.com - Investing.com Nigeria
Tempus AI launches pharmacogenomics testing nationwide - Investing.com
Tempus Launches Test for Therapies With Nearly 30% Severe Toxicities - Stock Titan
Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT) and Tempus AI, Inc. Class A (TEM) - The Globe and Mail
Tempus AI to Acquire Cancer Diagnostics Firm Personalis for approximately $1.5 Billion, Targeting MRD Market Leadership - finance.biggo.com
Tempus AI (TEM) On Its Personalis Deal And Whether The Bull Case Is Priced In - Yahoo Finance
Cathie Wood’s Tempus AI Bet Is Bleeding — And the Chart Looks Worse Than Wall Street Thinks - Sahm
Tempus to acquire Personalis, Inc. (PSNL) in cash and stock merger - Stock Titan
Tempus AI: Buy Rating Reaffirmed as Personalis Deal Strengthens MRD Position; $75 Price Target Maintained - TipRanks
Why Is Tempus AI Stock Volatile Tuesday?Personalis (NASDAQ:PSNL), Tempus AI (NASDAQ:TEM) - Benzinga
TEM, PSNL stocks are falling — why Morgan Stanley still likes Tempus AI’s Personalis deal - MSN
Tempus AI buys Personalis for $1.5 billion - grafa.com
Artificial Intelligence Stocks To Add to Your WatchlistJuly 21st - MarketBeat
Tempus AI Buys Personalis for $1.5B to Boost Cancer Monitoring - Medical Device and Diagnostic industry
Tempus Ai Inc (TEM) 財務データ
収益
当期純利益
現金流量
EPS
Tempus Ai Inc (TEM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Fukushima Ryan | CEO, Data |
Aug 03 '26 |
Sale |
46.19 |
23,818 |
1,100,076 |
143,945 |
1.15%
大文字化:
|
ボリューム (24 時間):